Risk factors associated with failing pre-transmission assessment surveys (pre-TAS) in lymphatic filariasis elimination programs: Results of a multi-country analysis
This paper reports for the first time factors associated with pre-transmission assessment survey (pre-TAS) results from a multi-country analysis. This information can help countries more effectively forecast program activities, such as the potential need for more rounds of mass drug administration, and prioritize resources to ensure adequate coverage of all persons in areas at highest risk of failing pre-TAS.
The Carter Center's Emily Griswold presents on improving mass drug administration tools on January 16, 2020.
Updates on operational research for lymphatic filariasis were shared from the Neglected Tropical Diseases Support Center on January 16, 2020.
RTI's Clara Burgert and Diana Lu talk about how to ensure high-quality standardized surveys on January 16, 2020.
IMA Tanzania's Andreas Nshala presents Tanzania's experience with conducting transmission assessment surveys for lymphatic filariasis on January 15, 2020.
IMA World Health's Abdel Direny, MD, MPH, presented guidance for transmission assessment survey preparation and supervision on January 15, 2020.
RTI's Clara Burgert leads a panel discussion on how to investigate and respond to LF survey failures on January 15, 2020.
USAID's Emily Toubali provided an overview of the NTD Division's work on lymphatic filariasis on January 14, 2020
The US Center for Disease Control and Prevention's Caitlin Worrell discussed filariasis test strip quality as a diagnostic tool and reporting issues with the tool on January 14, 2020.
The US Center for Disease Control and Prevention's Caitlin Worrell discussed filariasis test strip irregularity reporting in a bilingual presentation, titled "rapportage de irrégularités de FTS" in French, on January 14, 2020.